Skip to Main Content


2021 Lunch and Learn Series

Registration is now open for the Consortium’s 2021 Lunch and Learn series by clicking on the hyperlinked topics below. If a recording is available, it will be linked below after each webinar. Each talk listed below has been approved for .75 AMA PRA Category 1 credits. Please check this page for updates and additions to […]

Behavioral Health Transformational Task Force Begins Meetings

The Behavioral Health Transformational Task Force, created by SB21-137, met for the first time on Aug. 17. The group is tasked with issuing a report with recommendations to the General Assembly and the Governor about policies to create transformational change in the area of behavioral health using money the state receives from the federal American […]

2021 Legislative Wrap-Up

The 2021 session of the Colorado General Assembly ended June 8, following a packed calendar that saw the session draw to a close later than usual because of COVID-19 precautions.  This year was a successful one for funding the continuum of services addressing substance use, particularly compared to last year, when budgetary cuts reduced fiscal […]

Telligen honors Consortium as statewide champion

This Colorado Consortium for Prescription Drug Abuse Prevention’s response to joining Telligen to address high priority health issues during COVID-19 and beyond has demonstrated a high level of commitment toward the overall health of Colorado. The pandemic has not only highlighted the importance of community members working together, but also how collaboration can drive community-centered […]

Beyond the Numbers video series returns

Though it may be simpler to focus on the alarming and growing numbers of individuals experiencing a substance use disorder or losing their lives from an overdose, we must remember that every statistic is a person, a family member, a loved one, a friend. Every number has a story, and every community is impacted by […]

May 2021 legislative update

The last possible day for the 2021 legislative session is June 12. While there were hopes for the session to end late May, many anticipate session to close June 11. One major bill the Consortium has been tracking is SB21-137, referred to as the Behavioral Health Recovery Act of 2021. Among this bill’s provisions are […]

April 2021 Legislative Update

The Colorado General Assembly is past the midway point of its 2021 session, and lawmakers continue to work on a number of bills related to addressing the opioid crisis and proposed funding for services and programs for prevention, harm reduction, treatment and recovery support. One major bill the Consortium has been tracking is SB21-137, referred […]

Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One

On April 1st, the White House Office of National Drug Control and Policy announced seven priorities of the Biden-Harris administration for addressing the nation’s overdose and addiction crisis. The Administration’s memo identifies and explains the priorities and lists the strategies it will employ. The priorities are: Expanding access to evidence-based treatment. Advancing racial equity in […]

March 2021 legislative update

By José Esquibel Currently, four bills have been introduced in the current legislative session related to opioids and other substance use disorders. Here are brief summaries of the bills. This is up-to-date as of March 18 and synopsizes major provisions of the bills. Please visit the legislature’s page for the most recent versions with potential amendments. […]

Grant writing assistance returns for 2021

The Consortium is very pleased to announce the Grant Writing Assistance Program is resuming starting April 1, 2021! In 2019 and 2020, this program helped 23 organizations win a combined 30 grants totaling more than $5.5 million — a 24-to-1 return on the state’s $213,000 investment. The program will operate through December 31, 2021, or […]

Priorities of White House Office of National Control Policy

By José Esquibel The Biden-Harris Administration has released information on the priorities of the Office of National Control Policy (ONDCP). There is recognition that the COVID-19 pandemic has exacerbated the addiction and overdose crisis in the United States. ONCDP will have these policy priorities: The Workforce: Advancing recovery-ready workplaces and expanding the addiction workforce. Racial Equity: […]